wsbdaily | Thu, 21 Oct 2021 07:34:40 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
CRISPR Therapeutics AG(CRSP)
CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. The company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technology that allows for precise directed changes to genomic DNA. It has a portfolio of therapeutic programs in a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, and r... Read More
Summary & Charts
| Price | $ 98.37 | -1.89 (-1.89%) |
| Day's Range | $ 98.28 - 101.74 | |
| Previous Close | $ 100.26 | |
| Market Cap | $ 9.47B USD | |
| Short Interest % | 7.27 % | As of Wed, 31 Mar 2021 |
| Float | 61.39M | |
| Outstanding | 75.61M |
| Exchange | NasdaqGS | |
| Industry | Biotechnology | |
| Sector | Healthcare | |
| Volume | 1.19M | |
| Avg. Volume (20 day) | 1.68M | |
| Rel. Volume (20 day) | 0.70 | |
| Rel. Volume (3 month) | 0.96 | |
| Rating | A+ | Strong Buy |
| DCF | N/A | Strong Buy |
| Debt/Equity | 11.36 % | Neutral |
| ROE | 24.08 % | Buy |
| ROA | 15.40 % | Buy |
| P/E | 16.66 % | Buy |
| P/B | 2.86 % | Strong Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2021 | $ 100.50 | $ 101.74 | $ 98.28 | $ 98.37 | -1.89 | 1,185,956 | 0.70 | 0.96 | 3 |
| Oct 19, 2021 | $ 97.47 | $ 102.96 | $ 97.34 | $ 100.26 | +4.05 | 1,928,940 | 1.16 | 1.56 | 4 |
| Oct 18, 2021 | $ 97.34 | $ 97.47 | $ 95.68 | $ 96.21 | -0.79 | 1,269,856 | 0.79 | 1.04 | 6 |
| Oct 15, 2021 | $ 99.23 | $ 99.81 | $ 96.65 | $ 97.00 | -1.70 | 1,858,800 | 1.15 | 1.53 | 18 |
| Oct 14, 2021 | $ 98.35 | $ 102.64 | $ 96.60 | $ 98.70 | +1.93 | 2,910,114 | 1.81 | 2.42 | 4 |
| Oct 13, 2021 | $ 92.80 | $ 98.33 | $ 92.33 | $ 96.77 | -5.82 | 6,427,022 | 4.29 | 5.40 | 27 |
| Oct 12, 2021 | $ 101.25 | $ 104.79 | $ 100.63 | $ 102.59 | +1.94 | 1,321,970 | 1.09 | 1.17 | 22 |
| Oct 11, 2021 | $ 99.05 | $ 101.34 | $ 98.68 | $ 100.65 | +2.02 | 1,803,118 | 1.52 | 1.51 | 5 |
| Oct 08, 2021 | $ 102.79 | $ 102.91 | $ 96.55 | $ 98.63 | -4.36 | 3,476,863 | 2.99 | 2.80 | 7 |
| Oct 07, 2021 | $ 102.50 | $ 105.53 | $ 101.66 | $ 102.99 | +1.00 | 909,808 | 0.89 | 0.75 | 3 |
| Oct 06, 2021 | $ 101.82 | $ 103.77 | $ 99.10 | $ 101.99 | -0.50 | 1,180,630 | 1.16 | 0.97 | 4 |
| Oct 05, 2021 | $ 102.98 | $ 105.60 | $ 101.77 | $ 102.49 | +0.06 | 955,759 | 0.95 | 0.79 | 1 |
| Oct 04, 2021 | $ 110.00 | $ 110.01 | $ 102.23 | $ 102.43 | -8.86 | 1,766,624 | 1.77 | 1.45 | 1 |
| Oct 01, 2021 | $ 111.75 | $ 112.39 | $ 108.94 | $ 111.29 | -0.64 | 915,008 | 0.95 | 0.76 | |
| Sep 30, 2021 | $ 111.36 | $ 114.18 | $ 110.45 | $ 111.93 | +1.73 | 733,380 | 0.77 | 0.61 | |
| Sep 29, 2021 | $ 112.54 | $ 113.95 | $ 109.63 | $ 110.20 | -1.95 | 1,122,464 | 1.16 | 0.92 | 1 |
| Sep 28, 2021 | $ 115.57 | $ 115.78 | $ 111.88 | $ 112.15 | -5.11 | 1,274,429 | 1.34 | 1.04 | 2 |
| Sep 27, 2021 | $ 116.17 | $ 117.84 | $ 113.50 | $ 117.26 | +0.83 | 773,003 | 0.85 | 0.63 | 1 |
| Sep 24, 2021 | $ 119.51 | $ 120.24 | $ 116.01 | $ 116.43 | -4.82 | 1,086,071 | 1.19 | 0.89 | 2 |
| Sep 23, 2021 | $ 119.26 | $ 122.25 | $ 116.91 | $ 121.25 | +3.44 | 775,769 | 0.86 | 0.63 | 2 |
News
The latest news about CRISPR Therapeutics AG (CRSP).
The Motley Fool | 2021-10-20 06:10:00
The company's value isn't reflected in typical performance metrics.
24/7 Wall Street | 2021-10-19 15:18:14
Another day of strong earnings is pushing the broad markets higher across the board.
The Motley Fool | 2021-10-16 07:00:00
These two novel-drug makers could be top takeover targets next year.
Seeking Alpha | 2021-10-15 03:27:16
CRISPR Therapeutics was down at one point 10% after hours following reports of poorer than expected efficacy levels for its CTX110 CAR-T cell therapy. CRISPR is currently (55%) off all-time highs set at the beginning of 2021.
Zacks Investment Research | 2021-10-14 12:38:56
Here we discuss four biotech companies, CRSP, EDIT, SRPT and BEAM, that have the potential to gain from their promising gene therapy pipeline candidates.
24/7 Wall Street | 2021-10-14 09:41:38
A couple of ARK Invest funds run by ETF star Cathie Wood made a huge buy on Wednesday.
GlobeNewsWire | 2021-10-14 07:00:00
ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the appointment of Brendan Smith as Chief Financial Officer, effective today. Mr. Smith brings more than 20 years of financial, operational and strategic leadership experience, including as CFO of Translate Bio. He succeeds Michael Tomsicek, who is retiring after four years of service to the Company. It is expected that Mr. Tomsicek will remain with the Company in an advisory role through the end of 2021 to help ensure a smooth transition.
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2021-10-26 | BMO | -1.76 | -- | -- | 1.2M | -- | -- |
| 2021-07-29 | BMO | 4.19 | 9.44 | 125.29% | 421M | 0.9B | 113.98% |
| 2021-04-27 | BMO | -1.47 | -1.51 | 2.72% | 1.2M | 0.5M | -55.46% |
| 2021-02-16 | BMO | -1.27 | -1.50 | 18.11% | 2.5M | 370K | -85.2% |
| 2020-10-28 | BMO | -1.18 | -1.32 | 11.86% | 132K | 148K | 11.86% |
| 2020-07-27 | BMO | -0.95 | -1.30 | 36.84% | 32K | 44K | 36.84% |
| 2020-04-28 | BMO | -1.05 | -1.15 | 9.52% | 143K | 157K | 9.52% |
| 2020-02-12 | BMO | -0.63 | 0.51 | 180.96% | 95M | 77M | -19.05% |
Top Discussions
These are the top discussions over the last 24-hours that mention the CRSP stock ticker symbol.
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Tue, 13 Jul 2021 12:00 EST
@wsbdaily
wsbdaily